Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
60,775,042
-
Shares change
-
-544,940
-
Total reported value, excl. options
-
$2,247,652,301
-
Value change
-
-$21,551,953
-
Put/Call ratio
-
51%
-
Number of buys
-
96
-
Number of sells
-
87
-
Price
-
$36.98
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2019
240 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of 30 Sep 2019.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) had 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,775,042 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., STATE STREET CORP, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, ADAGE CAPITAL PARTNERS GP, L.L.C., and FIRST TRUST ADVISORS LP.
This table shows the top 207 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.